摘要
透明质酸(HA)是一种相对较新的药物传递系统的结构。CD44和HA运动介导的受体在内吞作用时发挥关键作用。通过利用HA作为药物载体,细胞摄取和肿瘤靶向给药的效率可以增加。目前,HA为物理封装或与各种药物化学共轭提供了有效的平台。在这篇综述中,我们总结了HA最新的研究进展,并对基于HA药物输送系统的应用前景进行了讨论。
关键词: CD44,化学改性,偶联物,衍生物,透明质酸,纳米载体。
图形摘要
Current Drug Targets
Title:Advances in Hyaluronic Acid-Based Drug Delivery Systems
Volume: 17 Issue: 6
Author(s): Yan Jiao, Xin Pang and Guangxi Zhai
Affiliation:
关键词: CD44,化学改性,偶联物,衍生物,透明质酸,纳米载体。
摘要: Hyaluronic acid (HA) is a relatively new polymer for the construction of drug delivery systems. CD44 and the receptor for HA-mediated motility play a key role in vivo for the receptormediated endocytosis of HA. Cellular uptake and the efficiency of tumor-targeted drug delivery are supposed to increase through utilizing HA as drug carriers. Currently, HA has provided a promising platform to physically encapsulate or chemically conjugate with various drugs. In this review, we presented the most latest advances in HA-based drug delivery systems and some forward-looking ideas are discussed.
Export Options
About this article
Cite this article as:
Yan Jiao, Xin Pang and Guangxi Zhai , Advances in Hyaluronic Acid-Based Drug Delivery Systems, Current Drug Targets 2016; 17 (6) . https://dx.doi.org/10.2174/1389450116666150531155200
DOI https://dx.doi.org/10.2174/1389450116666150531155200 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Application and Future Prospect of Extracellular Matrix Targeted Nanomaterials in Tumor Theranostics
Current Drug Targets Targeting Tumor Proteasome with Traditional Chinese Medicine
Current Drug Discovery Technologies Natural Products Targeting Autophagy via the PI3K/Akt/mTOR Pathway as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Gene Silencing in the Development of Personalized Cancer Treatment: The Targets, the Agents and the Delivery Systems
Current Gene Therapy Anesthetic Cardioprotection in Clinical Practice From Proof-of-Concept to Clinical Applications
Current Pharmaceutical Design A Sialic Acid-Specific Lectin from the Mushroom Paecilomyces Japonica that Exhibits Hemagglutination Activity and Cytotoxicity
Protein & Peptide Letters Cell Death in Mammalian Development
Current Pharmaceutical Design The Effects of Cantharidin and Cantharidin Derivates on Tumour Cells
Anti-Cancer Agents in Medicinal Chemistry Potential Utility of Mycobacterium w Vaccine in Control of Tuberculosis
Current Respiratory Medicine Reviews Sesamol: An Efficient Antioxidant with Potential Therapeutic Benefits
Medicinal Chemistry Nitric Oxide in Cancer Therapeutics: Interaction with Cytotoxic Chemotherapy
Current Pharmaceutical Design Proteome Analysis in Hematology Using Capillary Electrophoresis Coupled On-Line to Mass Spectrometry
Mini-Reviews in Medicinal Chemistry Cruciferous Plants: Phytochemical Toxicity Versus Cancer Chemoprotection
Mini-Reviews in Medicinal Chemistry Current and Future Applications of Probiotics
Current Nutrition & Food Science Inhibitors of ABL and the ABL-T315I Mutation
Current Topics in Medicinal Chemistry Overview of Systems Biology and Omics Technologies
Current Medicinal Chemistry Xeno-Cannibalism as an Exacerbation of Self-Cannibalism: A Possible Fruitful Survival Strategy for Cancer Cells
Current Pharmaceutical Design Review: Alternative Splicing (AS) of Genes As An Approach for Generating Protein Complexity
Current Genomics Molecular Cloning of a Novel PPEF-1 Gene Variant from a T-Cell Lymphoblastic Lymphoma Cell Line
Recent Patents on DNA & Gene Sequences Annexin A5 Imaging: An Academic Research – Clinical Trials and Theses
Current Molecular Imaging (Discontinued)